Paradigm Changes in Hodgkin’s Lymphoma Treatments

In this MEDtalk, Cathy Burton, consultant hematologist from Leeds, England, discusses treatment considerations for challenging populations with Hodgkin’s lymphoma, focusing on older patients, since there’s been a significant paradigm shift using targeted treatments in classical Hodgkin’s lymphoma. The study was presented at the 2024 ASCO annual meeting.